Measles virus suppresses interferon-α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-α receptor complex  by Yokota, Shin-ichi et al.
Measles virus suppresses interferon- signaling pathway: suppression
of Jak1 phosphorylation and association of viral accessory proteins,
C and V, with interferon- receptor complex
Shin-ichi Yokota,a Hiroyuki Saito,b Toru Kubota,a,1 Noriko Yokosawa,a
Ken-ichi Amano,c and Nobuhiro Fujiia,*
a Department of Microbiology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo 060-8556, Japan
b Department of Microbiology, Akita Prefectural Institute of Public Health, Akita 010-0874, Japan
c Central Research Laboratories, Akita University School of Medicine, Akita 010-8543, Japan
Received 26 June 2002; returned to author for revision 3 September 2002; accepted 24 September 2002
Abstract
To establish infections, viruses use various strategies to suppress the host defense mechanism, such as interferon (IFN)-induced antiviral
state. We found that cells infected with a wild strain of measles virus (MeV) displayed nearly complete suppression of IFN--induced
antiviral state, but not IFN--induced state. This phenomenon is due to the suppression of IFN--inducible gene expression at a
transcriptional level. In the IFN- signal transduction pathway, Jak1 phosphorylation induced by IFN- is dramatically suppressed in
MeV-infected cells; however, phosphorylation induced by IFN- is not. We performed immunoprecipitation experiments using antibodies
against type 1 IFN receptor chain 1 (INFAR1) and antibody against RACK1, which is reported to be a scaffold protein interacting with type
I IFN receptor chain 2 and STAT1. These experiments indicated that IFNAR1 forms a complex containing the MeV-accessory proteins C
and V, RACK1, and STAT1 in MeV-infected cells but not in uninfected cells. Composition of this complex in the infected cells altered little
by IFN- treatment. These results indicate that MeV suppresses the IFN-, but not IFN-, signaling pathway by inhibition of Jak1
phosphorylation. Our data suggest that functional disorder of the type I IFN receptor complex is due to “freezing” of the receptor through
its association with the C and/or V proteins of MeV.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Cells are provided with various defense mechanisms
against viral infection. The most important of these is the
establishment of an antiviral state induced by interferon
(IFN), which also has multiple functions to the cell (cell-
growth regulation, cell differentiation, and immune regula-
tion). The antiviral activity of IFN is due to IFN-inducible
proteins such as 2,5-oligoadenylate synthetase (2-5AS),
dsRNA-activated protein kinase (PKR), and MxA protein
(Fujii, 1994; Samuel, 1991; Sen and Ransohoff, 1993). The
expression of these proteins is induced by IFN upon acti-
vation of signal transduction pathway after IFN binds to
certain specific cell-surface receptors. The type I IFN,
namely IFN-/, receptor consists of two polypeptide
chains: human type I IFN receptor chain 1 (IFNAR1/IFN-
R) and human type I IFN receptor chain 2 (IFNAR2.2/
IFNAR2c/IFN-RL) (Mogensen et al., 1999). The intra-
cellular IFN signal transduction pathway consists of Janus
protein kinases (JAKs) and signal transducer and activator
of transcription (STAT) family proteins, as well as numer-
ous other cytokines (Stark et al., 1998). JAKs interact with
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cytoplasmic domain of IFN receptors. The type I IFN re-
ceptor associates with Jak1 and Tyk2, and the IFN- recep-
tor associates with Jak1 and Jak2. When type I IFN binds to
the specific receptor, tyrosine residues on the cytoplasmic
domain of IFNAR2.2 chain are phosphorylated (Wagner et
al., 2002). As a result, JAKs are activated by phosphoryla-
tion, and activated JAKs phosphorylate STATs, a compo-
nent of transcriptional factors that binds to IFN-responsive
promoter elements. IFN--responsive element, called the
IFN-stimulated response element (ISRE), activated by bind-
ing of the transcriptional factor ISGF3, which consists of
phosphorylated STAT1, phosphorylated STAT2 and IRF-9/
p48/ISGF3. IFN--responsive element, called the  acti-
vation sequence (GAS), activated by GAF, a homodimer of
phosphorylated STAT1 (Goodbourn et al., 2000; Sen and
Ransohoff, 1993).
Most DNA and RNA viruses have evolved the ability to
suppress the functions of these antiviral proteins to resist the
antiviral defense provided by IFN (Fujii, 1994; Garcia-
Sastre, 2001; Goodbourn et al., 2000). Furthermore, some
viruses have the capacity to block the IFN-mediated acti-
vation of the JAK/STAT signal transduction pathways using
several strategies such as the following: (i) suppression of
the phosphorylation of STATs and JAKs, (ii) inactivation of
components of the JAK/STAT pathway, and (iii) reduction
of the constitutive or basal levels of particular molecules
that contribute to the JAK/STAT pathway (Garcia-Sastre,
2001; Goodbourn et al., 2000; Joseph and Look, 2001;
Najarro et al., 2001; Tan and Katze, 2001; Yokota et al.,
2001).
Viruses belonging to family Paramyxoviridae block the
IFN signal transduction pathway using a variety of mecha-
nisms (Gotoh et al., 2001; Young et al., 2000). Sendai virus
(SeV) and human parainfluenza virus type 3 (hPIV3), both
belonging to genus respirovirus, reduce the levels of phos-
phorylation of STAT1 (Gao et al., 2001; Garcin et al., 1999;
Kato et al., 2001; Komatsu et al., 2000). Viruses belonging
to genus rubulavirus dramatically decrease the basal levels
of STAT proteins. Simian virus 5 (SV5) and mumps virus
(MV) reduce STAT1 protein levels (Didcock et al., 1999;
Fujii et al., 1999; Kubota et al., 2001; Yokosawa et al.,
1998), and parainfluenza virus type 2 (hPIV2) reduce
STAT2 protein levels (Nishio et al., 2001; Parisien et al.,
2001). Inhibition of the IFN-signaling pathway caused by
these viruses is shown to be mediated through viral acces-
sory proteins, such as V and C (Didcock et al., 1999; Garcin
et al., 1999; Kato et al., 2001; Kubota et al., 2001; Nishino
et al., 2001; Parisien et al., 2001). In viruses belonging to
genus pneumovirus, such as human respiratory syncytial
virus (hRSV), these events are not found, although hRSV is
able to circumvent the IFN response (Young et al., 2000).
Therefore, hRSV may have an alternative strategy. Viruses
belonging to genus morbillivirus should also suppress the
IFN response using an unknown strategy for suppression of
IFN- action.
Measles virus (MeV) is a member of genus morbillivirus.
Influence of MeV on IFN signaling pathway has been in-
vestigated using several classical (laboratory-adapted)
strains and vaccine strains of MeV. Suppression of IFN-
induced 2-5AS was shown in persistent infection of MeV
(Fujii et al., 1988, 1990). The events were shown to be
dependent on combinations of host cell types and virus
strains. For example, 2-5AS activity is significantly induced
by infection with Edmonston and CAM-70 strains in K562
cells, but merely induced by infection with AIK-C and Ha¨lle
strains (Fujii et al., 1988). Induction of 2-5AS by IFN
occurs mainly through activation of JAKs and STATs, as
well as other IFN-inducible genes. Several lines of evidence
reveal that MeV has the potential to block or suppress the
IFN response (Fujii et al., 1988, 1990). On the other hand,
wild strains of MeV isolated from the throat swabs of
patients with acute measles using marmoset cell line B95a
(Saito et al., 1992, 1994) were not able to propagate in
monkey kidney cell lines such as Vero cells. These clini-
cally isolated wild strains are found to have a hemagglutinin
(HA)-type distinct from that of classical strains such as the
Edmonston strain (Saito et al., 1994, 1995). In the present
study, we show that a wild strain of MeV suppresses the
IFN response, specifically through induction of IFN-induc-
ible genes, fluctuation of IFN-induced antiviral activity, and
inhibition of the JAK/STAT signaling pathway. Further-
more, we discuss the molecular mechanisms of this sup-
pression.
Results
AK-1 infection in human cell lines
Various cell lines were infected with a MeV wild strain
AK-1 and cultured for 14 days without any CPE. Viral load
increased in the infected cell lines K562, SiHa, CaSki,
SK-N-AS, and P3HR-1 as revealed by detecting HA
mRNA, and the HA mRNA was confirmed to be AK-1-
derived by polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP) (data not shown) in the
manner described previously (Saito et al., 1995). On the
other hand, AK-1 did not grow in U937 or Jurkat cells. MeV
infection in five cell lines was confirmed by expression of
MeV C and V proteins by using Western blotting, and cells
tested were positive for MeV antigens using fluorescein
isothiocyanate (FITC)-labeled rabbit anti-MeV antiserum
(data not shown). Infected cells produced progeny virus into
culture fluids, which induced significant syncytia formation
in B95a cells. These cell lines were confirmed to carry no
EB virus genome derived from AK-1 propagating cell B95a
by EBER transcripts that were not detectable by PCR (data
not shown). We also established cell lines infected with
other wild-type strains, AK-2, AK-3, AK-4, AK-5, and
AK-6, as above.
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AK-1-infected cells are resistant to IFN-, but not IFN-
We examined the IFN-induced antiviral activity in unin-
fected and AK-1-infected cells by determining CPE forma-
tion by VSV. AK-1-infected SiHa cells and AK-1-infected
CaSki cells showed nearly complete suppression of IFN--
induced resistance to VSV compared to uninfected cells
(Fig. 1). On the other hand, IFN--induced resistance to
VSV did not change in AK-1-infected cells compared to
uninfected cells.
We also determined efficacy of VSV replication in un-
infected and AK-1-infected cells (Table 1). SiHa and CaSki
cells showed a similar decrease in yields of VSV (105 order)
in the culture supernatant after treatment with both IFN-
and IFN-, although SiHa-AKV and CaSki-AKV displayed
similar yields of VSV between IFN--treated and untreated
cells. IFN--induced decreased yields of VSV were not
significantly affected by infection with AK-1. P3HR-1 also
showed that IFN- induced suppression of VSV replication
was clearly diminished by AK-1 infection. Because signif-
icant IFN--induced antiviral activity was not observed in
P3HR-1 cells, the cells are predicted to be unresponsive to
IFN-.
These results suggest that IFN--, but not IFN--, in-
duced antiviral activity is suppressed by infection with the
Fig. 1. Fluctuation of IFN-induced antiviral activity in cells with strain AK-1 of MeV. (A) SiHa cells (E) and AK-1-infected SiHa (SiHa-AKV) cells (F).
(B) CaSki cells (E) and AK-1-infected CaSki (CaSki-AKV) cells (F). The cells were treated with various concentrations of IFN- (top) or IFN- (bottom)
for 24 h at 37°C. Thereafter, VSV was challenged at an m.o.i. of 1.0. After cultivation, cell viability was determined by a dye-binding assay using gentian
violet.
Table 1
Efficacy of VSV replication after treatment with IFN in MeV strain AK-
1-infected SiHa, CaSki, and P3HR-1 cells
Cells IFN Yield of VSV
(PFU/ml)
SiHa — 2.4  108
 3.2  103
 4.4  103
SiHa-AKV — 1.7  108
 2.4  108
 2.8  104
CaSki — 1.7  108
 2.0  103
 2.6  103
CaSki-AKV — 1.1  108
 9.2  107
 3.8  104
P3HR-1 — 1.5  108
 1.0  103
 4.8  107
P3HR-1-AKV — 6.7  107
 2.2  108
 8.6  106
Note. Cells were treated with IFN- or IFN- at a concentration of 103
IU/ml for 24 h at 37°C and then challenged with VSV. Virus titer in the
resulting supernatant was determined by a plaque-forming assay using
Vero cells as indicator cells.
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AK-1 strain of MeV. Similar results were obtained in cells
infected with other MeV wild-type strains (data not shown).
Effect of MeV infection on induction of IFN-inducible
antiviral genes
We examined the expression of IFN-inducible genes in
AK-1-infected and uninfected cells at mRNA level as de-
termined by RT-PCR (Fig. 2). The induction of 2-5AS
mRNA by IFN- was inhibited in the AK-1-infected cells
tested, such as CaSki-AKV, SK-N-AS-AKV, and P3HR-1-
AKV, compared with uninfected controls. Induction of
IRF-1 mRNA by IFN- in CaSki-AKV and SK-N-AS-AKV
cells was detected with a slight reduction compared to the
uninfected controls. IRF-1 mRNA was not induced by
IFN- in P3HR-1 cells (data not shown). Consistent with
the results of antiviral activity (Table 1), P3HR-1 cells have
no or a low response to IFN-.
Furthermore, we examined the effect of MeV infection
on IFN-inducible gene expression by a luciferase reporter
gene assay. To examine the response to IFN-, five tandem
repeats of ISRE were used as enhancer elements of the
firefly luciferase gene. We used a dual luciferase assay
system using the Renilla luciferase gene under the control of
the HSV thymidine kinase promoter as a control for trans-
fection efficacy. Treatment with 1000 IU/ml IFN- for 24 h
increased firefly luciferase activity about 8- and 13-fold in
SiHa and CaSki cells, respectively, as compared to the
untreated control. In the AK-1-infected cells (SiHa-AKV
and CaSki-AKV), IFN--induced reporter activity was 1.7-
and 2.2-fold, respectively, compared to the untreated con-
trol (Fig. 3). Induction of reporter gene expression by IFN-
was dramatically suppressed in AK-1-infected cell lines. To
examine IFN--induced gene expression, four tandem re-
peats of the GAS element were used as an enhancer element
for the firefly luciferase gene with no significant difference
Fig. 2. mRNA levels of IFN-inducible genes, 2-5AS, and IRF-1 in cells infected with MeV strain AK-1. Targets used were 40 kDa 2-5AS and IRF-1 as an
IFN--inducible gene and an IFN--inducible gene, respectively. (A) CaSki and CaSki-AKV cells. (B) SK-N-AS and SK-N-AS-AKV cells. (C) P3HR-1 and
P3HR-1-AKV cells. GAPDH used as a control.
Fig. 3. Effect of MeV strain AK-1 infection on induction of IFN-inducible genes as determined by a reporter gene assay in SiHa and CaSki cells. Cells with
or without AK-1 infection were transfected with reporter plasmids containing luciferase reporter genes linked to IFN-responsive enhancers, pIRSE-Luc for
IFN- stimulation and pGAS-Luc for IFN- stimulation, plus pRL-TK as an internal reference for transfection efficacy. The transiently expressed
transfectants were treated with 1000 IU/ml IFN- or IFN- for 24 h. The cell lysates were assayed for luciferase activity. All experiments were performed
in quadruplicate. The results are expressed as fold induction relative to the values obtained from experiments without IFN treatment.
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in induction of reporter activity by IFN- treatment between
SiHa and SiHa-AKV cells. In the case of CaSki, induction
by IFN- was slightly enhanced by AK-1 infection (Fig. 3).
Consistent results were observed in protein levels of the
IFN-inducible genes. We determined protein levels of
STAT1 (inducible by both IFN- and IFN-), p68PKR
(IFN--inducible), and IRF-1 (IFN- inducible) in K562
and K562-AKV cells (Fig. 4) IFN--induced upregulation
of STAT1 and p68PKR was severely decreased in K562-
AKV. On the other hand, IFN--induced upregulation of
STAT1 and IRF-1 protein levels were not altered by AK-1
infection.
The results indicate that the inhibition of IFN--induced
antiviral activity by MeV infection is due to suppressed
expression of IFN-inducible genes in response to IFN-.
Basal protein levels of STATs and IRF-9 in MeV-infected
cells
To determine the suppression mechanism of IFN-induc-
ible gene expression by MeV infection, we first used West-
ern blotting to investigate changes in protein levels of
STAT1, STAT2, and IRF-9/p48, all of which contribute to
the IFN- intracellular signaling pathway in cells with or
without MeV infection (Fig. 5). Varied patterns were ob-
served among cell lines. For example, STAT2 and IRF-9
increased in AK-1-infected CaSki cells. STAT1 and IRF-9
increased in AK-1-infected P3HR-1 cells. On the other
hand, STAT1 decreased in AK-1-infected SK-N-AS cells.
Protein levels of JAKs did not show significant differences
between uninfected and AK-1-infected cells of SiHa and
CaSki (Fig. 6). These results indicate that changes in protein
levels of STAT1, STAT2, IRF-9, and JAKs do not contrib-
ute to suppression of IFN-induced antiviral activity.
Suppression of IFN--induced JAK phosphorylation in
MeV-infected cells
We investigated the suppression of IFN--induced
events in AK-1-infected cells as it relates to the JAK/STAT
pathway level. Figure 7 shows activation (namely phos-
phorylation status) of STAT1 and JAKs in SiHa and SiHa-
AKV cells during treatment with IFN- or IFN-. In SiHa-
AKV cells, IFN--induced phosphorylation of STAT1 and
Jak1 was dramatically suppressed more than 95% at 20 min
treatment compared with the uninfected control (Fig. 6A).
On the other hand, IFN--induced Tyk2 phosphorylation,
and IFN--induced phosphorylation of STAT1, Jak1, and
Jak2, did not show significant changes following AK-1
infection. Similar results were observed in CaSki and
CaSki-AKV cells. IFN--induced phosphorylation of
STAT1 and Jak1 inhibited almost completely and 84% at 10
min treatment, respectively (Fig. 6B). Although IFN--
induced phosphorylation of STAT1 and Jak1 was clearly
inhibited in CaSki-AKV cells, IFN--induced phosphoryla-
tion was not. Interestingly, IFN--induced phosphorylation
of Jak1 and Jak2 was prolonged and enhanced 20 min after
induction in CaSki-AKV cells compared to uninfected cells
(Fig. 6B). This result may be consistent with the finding that
inducibility of reporter gene expression under the GAS
promoter by IFN- is slightly enhanced in CaSki-AKV cells
compared to CaSki cells (Fig. 3).
Viral proteins, C and V, interact with type I IFN receptor
Suppression mechanism of the IFN-signaling pathway
by MeV is very interesting, because IFN--induced Jak1
phosphorylation, but not IFN--induced phosphorylation, is
specifically suppressed. These results suggest that MeV
interferes with the IFN--signaling pathway upstream of the
Jak1 phosphorylation step. Thus, we tried to determine the
components of the type I IFN receptor (IFNAR) complex in
uninfected and AK-1-infected cells by immunoprecipitation
analysis (Fig. 7). First, we performed immunoprecipitation
using the anti-IFNAR1 antibody. The immunoprecipitates
obtained from SiHa-AKV cell lysate contained viral pro-
teins C and V, STAT1, and receptor for activated C kinase
 (RACK1), together with IFNAR1. The other viral pro-
teins are not detected in the precipitates as shown by im-
Fig. 5. Fluctuation of basal protein expression levels of STAT1, STAT2,
and IRF-9 in MeV strain AK-1-infected cells. Cultured cells were collected
and lysed. The lysates (50 or 5 g/lane) were applied to SDS–PAGE on a
7.5% (for STAT1 and STAT2) or 12.5% (for IRF-9 and actin) acrylamide
gel and analyzed by Western blotting. n.d.: not detectable.
Fig. 4. Effect of MeV strain AK-1 infection on induction of protein levels of
IFN-inducible STAT1, p68PKR, and IRF-1 in K562 and AK-1-infected K562
cells. K562 and K562-AKV cells were treated with IFN- or IFN- at 1000
IU/ml at 37°C for 24 h. The cell lysates (50 or 5 g/lane) were applied to
SDS–PAGE on a 7.5 or 10% acrylamide gel and analyzed by Western blotting.
C: control (no treatment); : IFN- treated; : IFN- treated.
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munoblotting with anti-MeV M and anti-MeV N (lowest
panels of Fig. 7). We also examined immunoprecipitation
using anti-IFN- receptor (IFN-R) antibody. Any of
these MeV proteins did not coprecipitate with the anti-IFN-
R antibody (data not shown). This indicated that copre-
cipitation of these MeV proteins with anti-IFNAR1 anti-
body was due to formation of a specific complex with
IFNAR. The components of this interaction did not signif-
icantly change after IFN- treatment for 20 min; however,
the amounts of STAT1 and MeV C and V proteins copre-
cipitated with IFNAR1 were reduced (Fig. 7B). Further-
more, phosphorylated STAT1 was not detected in the pre-
cipitates even after IFN treatment by Western blotting (data
not shown). Interestingly, precipitated IFNAR1 by anti-
IFNAR1 antibody slightly increased at 10 min IFN treat-
ment in both uninfected and infected cells. The reason was
obscure; however, the result was reproducible.
RACK1 is a member of G protein family and acts as a
scaffold protein. It has been reported that RACK1 interacts
with many proteins, including IFNAR2.2 and inactivated
(unphosphorylated) form of STAT1 (Croze et al., 2000;
Usacheva et al., 2001). On the other hand, STAT1 protein
cannot be detected in the immunoprecipitate obtained from
SiHa cells (Fig. 7B). Next, we performed immunoprecipi-
tation using the anti-RACK1 antibody (Fig. 7C). In unin-
fected SiHa cells, IFNAR1 and STAT1 were coprecipitated
with RACK1. IFNAR1 and STAT1 precipitated by anti-
RACK1 antibody seemed to interact with independent
RACK1 molecules and did not exist on the same complex,
as shown in Fig. 8, because STAT1 did not coprecipitated
with IFNAR1 (Fig. 7B). Furthermore, the coprecipitated
STAT1 with RACK1 diminished following IFN- treat-
ment. This result is consistent with the report that RACK1
interacts with the resting form of STAT1 but not with its
activated (phosphorylated) form (Croze et al., 2000). Inter-
estingly, larger amounts of IFNAR1 were found in precip-
itates obtained from SiHa-AKV than in precipitates ob-
tained from SiHa. It seems that the IFNAR1 complex
Fig. 6. Effect on IFN-induced phosphorylation of STAT1 and JAKs by MeV strain AK-1 infection in SiHa (A) and CasKi (B) cells. SiHa, SiHa-AKV, CasKi,
and CasKi-AKV cells were treated with IFN- or IFN- at 1000 IU/ml at 37°C for 10 or 20 min. The cell lysates (50 g/lane) were applied to SDS–PAGE
on a 7.5% polyacrylamide gel and analyzed by Western blotting. Protein levels of STAT1 and JAKs in the untreated control are presented as a representative
result. Protein levels did not change during IFN treatment (data not shown). C: control experiment without IFN treatment; : IFN- treatment; : IFN-
treatment.
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containing RACK1 and MeV C and V is very tight and large
in the infected SiHa cells, so anti-RACK1 antibody can
precipitate it with high avidity. This speculation is sup-
ported by the fact that this complex was detected under
higher stringency condition using a RIPA buffer containing
0.5% Nonidet P-40, 0.5% sodium deoxycholate, and 0.02%
Sodium dodecyl sulfate (SDS), although the interactions of
STAT1, RACK1, and IFNAR1 in uninfected cells were
dramatically reduced (data not shown). Proteins C and V,
but not other MeV proteins, were found to interact with the
IFNAR1-STAT1-RACK1 complex in SiHa-AKV. This in-
teraction was not drastically changed by IFN-; however,
the amount of STAT1, RACK1, and MeV proteins tended to
decrease following IFN- treatment for 20 min. Similar
results were observed in CaSki and CaSki-AKV cells (data
not shown). These lines of evidence suggest that the IF-
NAR-STAT1-RACK1 complex interacts with MeV C and
V proteins and this complex is stabilized in AK-1-infected
cells.
We also performed immunoprecipitation using anti-C
and anti-V antibodies. Both antibodies can precipitate only
a small part of proteins in cell lysates, and therefore neither
Fig. 7. Immunoprecipitation analysis of type I IFN receptor complex in SiHa and MeV strain AK-1-infected SiHa cells by using anti-IFNAR1 antibody (B)
and anti-RACK1 antibody (C). SiHa and SiHa-AKV cells were treated with IFN- at 1000 IU/ml for 10 or 20 min. IFNAR1- and RACK1-interacting proteins
were precipitated from cell lysates using the relevant antibodies. The precipitates were analyzed by Western blotting (WB) using antibodies indicated on the
left side of the column. As a control, Western blots of the total cell lysates are shown in (A).
Fig. 8. Proposed scheme for suppression of IFN- signaling pathway by MeV. In MeV-infected cells, IFN- receptor complex is “frozen” by the association
of viral accessory proteins, C and V, and consequently IFN- signal is not transduced.
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IFNAR1, STAT1, nor RACK1 were detected in the immu-
noprecipitates. This may be due to the fact that the anti-C
and anti-V antibody-binding sites are also involved in in-
teraction with the IFNAR-STAT1-RACK1 complex.
Discussion
In the present study, we show the suppression of an
innate immune response, IFN-induced antiviral activity, fol-
lowing MeV infection. We used the MeV wild strains,
AK-1, AK-2, AK-3, AK-4, AK-5, and AK-6 (Saito et al.,
1992, 1994) to infect various types of cells, including epi-
theloid carcinoma cells (SiHa and CaSki), lymphoid cells of
B cell origin (P3HR-1), chronic myelogenous leukemia
cells (K562), and neuroblastoma cells (SK-N-AS). MeV
infection of these cells commonly resulted in inhibition of
IFN--induced antiviral activity (Figs. 1, 2, and Table 1).
We examined the inhibition mechanism step by step. IFN-
-induced transcriptional activation of ISRE, an IFN--
responsive element, was not observed by a reporter gene
assay and activation of STAT1, a component of the tran-
scriptional factor ISGF3, was not induced by IFN-. Nu-
merous viruses of genus rubulavirus, a genus of Paramyxo-
viridae, share the ability to dramatically decrease basal
levels of STAT proteins due to the effects of their V protein
(Didcock et al., 1999; Kubota et al., 2001; Nishio et al.,
2001; Parisien et al., 2001; Yokosawa et al., 1998). MeV (of
the genus morbillivirus) changed basal protein levels of
STAT1, STAT2, and IRF-9 in some cases (Fig. 5); how-
ever, there is no correlation between basal levels of these
proteins and the ability of the virus to inhibit the innate
antiviral activity of cells. Inhibition of antiviral activity by
MeV was shown to be due to suppression Jak1 phosphor-
ylation, which was induced by IFN-, but not by IFN-. So
we believed that the effect on IFN- signaling was not
mediated by a direct interaction with Jak1. Therefore, we
examined proteins associated with the type I IFN receptor
by immunoprecipitation analysis (Fig. 7). We demonstrated
that the scaffold protein RACK1 is an important component
of the type I IFN receptor complex. RACK1 is a 36,000 Da
protein composed of seven WD motif, which consists of
about 40 amino acid residues terminated with tryptophan
and aspartic acid residues, repeats that resemble the struc-
ture of the  subunit of G protein (Mochly-Rosen et al.,
1995; Neer and Smith, 1996; Ron et al., 1994). RACK1 is
considered a scaffold protein. It has been reported to interact
with many cellular proteins, including protein kinase C
(Mochly-Rosen et al., 1995), Src (Chang et al., 2001),
common  subunit of GMCSF/IL-3/IL-5 receptors (Geijsen
et al., 1999), insulin-like growth factor-I receptor (Her-
manto et al., 2002), -integrins (Liliental and Chang, 1998),
and protein tyrosine phosphatase  (Mourton et al., 2001).
RACK1 is believed to modulate cellular signaling path-
ways, cell migration, and cell-to-cell-contact. Interestingly,
RACK1 also interacts with IFNAR2.2, type I IFN receptor
chain 2 (Croze et al., 2000), and unphosphorylated STAT1
(Usacheva et al., 2001); it is required for recruitment and
activation of IFN--induced STAT1 activation and trans-
duction of IFN- signaling. In addition, it can associate with
various viral proteins, including adenovirus E1A protein
(Sang et al., 2001), Epstein–Barr virus BZLF1 protein (Bau-
mann et al., 2000), human immunodeficiency virus-1 Nef
protein (Gallina et al., 2001), and influenza A virus M1
protein (Reinhardt and Wolff, 2000). More recently, by
using yeast two-hybrid system, we found that V protein of
mumps virus interacted with RACK1 (Kubota et al., 2002).
Our immunoprecipitation study (Fig. 7) is explained by
showing that RACK1 interacts with either type I IFN re-
ceptor complex and/or STAT1 and that it releases activated
STAT1 from the receptor following IFN- treatment in
uninfected cells. This is consistent with previous observa-
tions (Croze et al., 2000). On the other hand, IFNAR1/
IFNAR2.2, RACK1, STAT1, and MeV proteins V and C
formed tight complexes in MeV-infected cells. The com-
plexes were only slightly altered by IFN- treatment for 20
min (Fig. 7). We propose that type I IFN complex, which
contains IFNAR1, IFNAR2.2, RACK1, and STAT1, is “fro-
zen” by association with the MeV accessory proteins C
and/or V (Fig. 8). The C and/or V proteins should contribute
to the suppression of IFN- signal pathway; however, it is
still unclear whether C and V have a direct or indirect role
in the function of type I IFN receptor. For example, it is not
known whether the C and/or V proteins play a role in the
phosphorylation of Jak1 or the phosphorylation of IFNAR.
MeV C and V proteins were reported to interact some
cellular proteins of host cells and considered to alter some-
what host cellular responses (Lin et al., 1998; Liston et al.,
1995). However, these interacting proteins were not identi-
fied except one of the V interacting proteins is damage-
specific DNA-binding protein (Lin et al., 1998), the rela-
tionship between these proteins and our results have not
been defined.
Contribution of C and V proteins on MeV pathogenicity
has been studied using defective recombinant viruses gen-
erated by a reverse genetics system. Both the C-defective
virus and the V-defective virus multiply in Vero cells with-
out obvious impairment (Radecke and Billeter, 1996;
Schneider et al., 1997); however, the C-defective virus rep-
licates with severely reduced efficacy in peripheral blood
mononuclear cells (Escoffier et al., 1999). Compared to the
parent MeV and other mutants, the V-defective virus shows
milder clinical symptoms and a lower mortality rate in a
human CD46-transgenic mouse model (Patterson et al.,
2000) and prolonged thymocyte survival in a mouse-en-
grafted human thymus/liver implants model (Valsamakis et
al., 1998). Mrkic et al. (2000) reported that the C- or
V-defective MeV mutant showed less pathogenicity than
the parent MeV in genetically engineered mice defective for
the IFNAR and expressing human CD46. The results sug-
gest that there is a mechanism other than the counteracting
IFN system in pathogenicity of C and V proteins. However,
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it is also possible that mutant strains of MeV with high
sensitivity to IFN show reduced pathogenicity compared to
parent strains of MeV, which has the ability to suppress the
IFN signaling pathway. Furthermore, the results described
above were obtained from experiments using C- or V-
deficient mutants generated from c-DNA based on a classi-
cal strain, Edmonston. It is, therefore, necessary to investi-
gate the pathogenicity of mutant strain derived from other
MeV strains, such as AK-1.
Similar to other viruses, MeV induces IFN production
via activation of transcription factors, such as STATs and
NF-B, which also contribute to the expression of various
cytokines and inflammatory mediators. IFN-/ plays an
important role in the establishment of an antiviral state.
Recently, a virus-induced IFN production system was
clearly described (Mamane et al., 1999; Sato et al., 2000).
Briefly, when virus or dsRNA attacks cells, small amounts
of IFN- and a specific subtype of IFN- is induced by
transcriptional activation contributing the transcription fac-
tors, including IRF-3, ATF2/c-jun, and NF-B. The primar-
ily produced IFN acts in a positive feedback mechanism to
induce IRF-7 via the JAK/STAT pathway, namely contri-
bution of ISGF3. Consequently, large amounts of IFN-/
containing various subtypes of IFN- are produced by the
contribution of the IRF-3/IRF-7 complex in cooperation
with ATF2/c-jun and NF-B. MeV strain AK-1 should
inhibit the latter system, namely, large amounts of IFN
production via the JAK/STAT pathway. Naniche et al.
(2000) reported that wild strains of MeV downregulate IFN
production in peripheral blood lymphocytes, unlike Vero
cell-adapted virus. On the other hand, Helin et al. (2001)
reported that a Vero cell-grown MeV strain can activate
NF-B and STATs and induce higher production of IFN-
/ compared to virulent MeV strains. It is very interesting
what factor(s) contributes to the ability, namely suppression
of IFN-/ production, by wild strains of MeV. However,
Naniche et al. (2000) stated that the suppression of IFN-/
production does not seem to be due to a block in IFN
signaling pathway because the levels of STAT1 protein, an
IFN-inducible protein, are increased in response to a viral
infection to comparable levels observed after IFN treatment.
The suppression of IFN- signal transduction pathway by
wild strains of MeV, that is our finding in the present study,
should allow for the suppression of IFN-/ production. It
may enable the wild MeV strain AK-1 easy transition to
persistent infection. In fact, we observed that strain-AK1-
infected cells produce undetectable or very low amounts of
IFN-/ (data not shown).
Materials and methods
Cells and viruses
Human cell lines P3HR-1 (lymphoid cells of B cell
origin), K562 (chronic myelogenous leukemia cells), SK-
N-AS (neuroblastoma cells), SiHa, CaSki (epitheloid carci-
noma cells), U937 (monocytic lymphoma), Jurkat (T cell),
and marmoset cell line B95a were routinely cultured in
RPMI 1640 medium containing 10% (v/v) heat-inactivated
fetal bovine serum, 100 U/ml penicillin, and 100 g/ml
streptomycin. The wild-type strains of MeV (AK-1, AK-2,
AK-3, AK-4, AK-5, and AK-6) were isolated from throat
swabs of patients with clinical measles using B95a cells
(Saito et al., 1992, 1994, 1995). The viruses used in this
study was propagated in B95a cells.
Reagents
IFN- and IFN- were purchased from Serotec (Oxford,
U.K.) and Genzyme (Cambridge, MA), respectively. Both
were used at a final concentration of 1000 IU/ml. Rabbit
polyclonal antibodies against STAT1 p84/p91 (E-23),
STAT2 (C-20), Jak2 (M-126), IRF-1 (C-20), RACK1 (H-
187), IFNAR1/IFN-R (R-100), and IFN-R (C20), and
mouse monoclonal antibody against IFNR1 (H-11) and
IFN-R (GIR-94), were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA). Rabbit antibodies against
Jak1 and Tyk2 were acquired from Upstate Biotechnology
(Lake Placid, NY). Rabbit antibodies against Tyr1022/1023-
phosphorylated Jak1 and Tyr1007/1008-phosphorylated Jak2
were acquired from BioSource International (Camarillo,
CA). Rabbit antibodies against Tyr701-phophorylated
STAT1 and Tyr1054/1055-phosphorylated Tyk2 were ac-
quired from Cell Signaling Technology (Beverly, MA).
Mouse monoclonal antibodies against IRF-9/p48 (clone 6),
p68PKR (clone 13), and RACK1 (clone 20) were acquired-
from Transduction Laboratories (San Diego, CA). Mouse
monoclonal antibodies against actin (C4), MeV M protein,
and MeV N protein were acquired from Chemicon (Tu-
mecula, CA). Rabbit anti-MeV C protein and anti-MeV V
protein antibodies were kindly donated by Drs. Atsushi
Kato and Kaoru Takeuchi (National Institute of Infectious
Diseases, Tokyo, Japan).
Western blotting
Cells were lysed with 1% Nonidet P-40, 120 mM NaCl,
1 mM dithiothreitol, 10% glycerol, 5 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 1 mM Na3VO4, 1 mM NaF,
and 20 mM HEPES–NaOH, pH 7.5, and the lysates were
centrifuged at 10,000 g for 10 min at 4°C. The supernatants
were recovered, and the protein concentration was deter-
mined by the method of Bradford (1976) using bovine
serum albumin as a standard. Sodium dodecyl sulfate–poly-
acrylamide gel electrophoresis (SDS–PAGE) and Western
blotting were carried out as described previously (Yoko-
sawa et al., 1998; Yokota et al., 2001). Alkaline phosphatase
labeled goat anti-mouse or rabbit Ig antibody (BioSource
International) and bromochloroindolyl phosphate/nitroblue
tetrazolium were used as a secondary antibody and an en-
zyme substrate, respectively.
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RT-PCR and PCR-RFLP
Total RNA was isolated from cells using Isogene (Nip-
pon Gene, Toyama, Japan) and then treated with DNase
(Message clean kit, Gen Hunter, Brookline, MA).
The infection of MeV strain AK-1 was confirmed by de-
tection of viral HA expression using RT-PCR (Saito et al.,
1995). A 344-bp fragment (nucleotide 1068 to 1416) was
amplified using rTth polymerase (Toyobo, Osaka, Japan). For
identification of the wild-strain AK-1, the RT-PCR fragment
was digested with Sau3A1 and the fragmentation pattern was
analyzed by 2.5% agarose electrophoresis.
Transcriptional levels of the 40-kDa isozyme of 2-5AS
and IRF-1 induced by treatment with IFN- and IFN-,
respectively, were determined by RT-PCR analysis using an
appropriate primer set in the same manner as described
previously (Fujii et al., 1996, 1999). A 266-bp fragment
(nucleotide 1039 to 1304) was amplified for detecting
mRNA of 40 kDa 2-5AS. A 299-bp fragment (nucleotide
874 to 1172) was amplified for detecting mRNA of IRF-1.
A 450-kb fragment of glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) mRNA amplified by primer set, 5-TC-
CACCACCCTGTTGCTGTA-3 (reverse) and 5-ACCA-
CAGTCCATGCCATCAC-3 (forward), was used as a
control.
Induction of an antiviral state following IFN treatment
Antiviral state induced by IFN was examined by two
methods: cytopathic effect (CPE) caused by vesicular sto-
matitis virus (VSV) infection and reduction of VSV repli-
cation. CPE assay was carried out as follows: Uninfected
and AK-1-infected cells were cultured in 96-well microtiter
plates in the presence of various concentrations of IFN- or
IFN- for 24 h and then challenged with 0.1 ml VSV (2 
104 PFU/ml). The cells were stained with gentian violet
when a cytopathic effect was obvious. After dissolving dye
bound to viable cells with methylcellosolve, the absorbance
at 550 nm was measured. VSV reduction assay was carried
out as follows: Cells cultured at approximately 80% con-
fluency were treated with 1000 IU/ml of IFN- or IFN- for
24 h and then challenged with VSV at an m.o.i. of 1.0 at
room temperature. Virus titer in the culture fluids at 24 and
48 h after infection was determined using Vero cells as an
indicator.
Luciferase reporter gene assay
Expression of IFN-inducible genes was determined by a
dual luciferase reporter assay by transiently transfecting
reporter plasmids containing either the ISRE or the GAS
enhancer element. The firefly luciferase reporter plasmids,
pISRE-Luc and pGAS-Luc (PathDetect in Vivo Signal
Transduction Pathway cis-Reporting Systems), were pur-
chased from Stratagene (La Jolla, CA). Cells were plated
onto a 24-well plate at approximately 30% confluency the
day before transfection. Reporter plasmids (1 g) and ref-
erence plasmids (0.1 g of pRL-TK vector, harboring HSV
thymidine kinase promoter just upstream of Renilla lucif-
erase gene, Promega, Madison, WI) were mixed and trans-
fected into cells using Superfect transfection reagent (Qia-
gen, Hilden, Germany) according to the manufacturer’s
instructions. After cultivation for 24 h, IFN- (for pISRE-
Luc transfectants) or IFN- (for pGAS-Luc transfectants)
was added at a final concentration of 1000 IU/ml, and cells
were incubated for 24 h. The cells were lysed, and the firefly
luciferase and Renilla luciferase activities in the lysate were
measured using Dual-Luciferase Reporter Assay System
(Promega). The experiments were performed in quadrupli-
cate. Reporter activity was calculated as the ratio of firefly
luciferase activity to Renilla luciferase activity. The results
are expressed as fold induction, which is the value relative
to the value of control experiments without IFN treatment.
Immunoprecipitation analysis
Cellular proteins were solubilized by RIPA buffer (1%
Nonidet P-40, 0.1% sodium deoxycholate, 100 mM NaCl, 4
mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 0.2
mTIU/ml aprotinin, 1 mM Na3VO4, 1 mM NaF, and 50 mM
HEPES–NaOH, pH 7.5). The cell lysate and 5 g antibody
were mixed and incubated at 4°C for 1 h. Protein A–Sepha-
rose 4B (Amersham Biosciences AB, Uppsala, Sweden)
was added to the mixture and incubated at 4°C overnight on
a rotator. The resin was washed with the RIPA buffer four
times and then the bound materials were solubilized by
boiling with SDS–PAGE sample buffer and applied to
SDS–PAGE, followed by Western blotting analysis as de-
scribed above.
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